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ABSTRACT
Introduction: Cost-effectiveness is an important
criterion in the decision to cover interventions in health
insurance packages. One of the outcome measures, the
quality-adjusted life year, has been criticised on its
assumptions and implications concerning life
expectancy and quality of life. Several studies have been
conducted that measured societal preferences
concerning healthcare rationing decisions. These
studies mainly focused on one attribute. To adjust
quality-adjusted life year maximisation in accordance
with societal preferences, the relative importance of
attributes should be studied. The present study aims to
measure the relative importance of age, gender,
socioeconomic status, pre-intervention health state,
treatment effect, chance of treatment success and
number of people in need of the intervention. A
secondary objective is to compare the validity of the
willingness to pay method with the validity of a relatively
new preference elicitation method, besteworst scaling.
Methods and analysis: A representative sample of
2000 Dutch citizens, over 18 years of age, are
recruited to complete a web-based survey containing
treatment scenarios. The scenarios present different
levels of attributes. Respondents are asked to select
one of the four scenarios that they prefer to be covered
by the Dutch standard health insurance package and
one that they prefer not to be covered. They are also
asked to indicate how much they are willing to pay for
each treatment scenario. At the end of the survey,
respondents are asked to rate every attribute on
a1 e10 scale. Two versions of the questionnaire are
developed which differ on the framing, that is,
treatments can be added to or removed from the
insurance package. The data will be analysed by means
of sequential conditional logit analysis (besteworst
scaling) and analysis of variance (willingness to pay).
Ethics and dissemination: The protocol is reviewed
and approved by the medical ethical committee of the
University Medical Center Leiden.
INTRODUCTION
In the Netherlands, standard health insurance
is compulsory for every citizen. The Minister
of Health decides which interventions are to
be covered by obtaining advice from the
Health Care Insurance Board (CVZ). Their
advice is based on four criteria: necessity,
effectiveness, feasibility and cost-effectiveness.
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The cost-effectiveness of interventions is
determined by relating the difference in cost
between the intervention and usual care to the
difference in effects in terms of quality-
adjusted life years (QALYs). QALYs represent
the equivalent number of years a person will
live in perfect health as a result of an inter-
vention.
2 Interventions that gain the most
QALYs relative to their cost are prioritised over
others (QALY maximisation). The underlying
value of this prioritisation rule is that a QALY
gained has the same value no matter who
gains it (distributive neutrality).
3 However,
implicit weightings occur when comparing
interventions treating speciﬁc patient groups.
4
For example, interventions for children are
likely to gain more QALYs compared with
interventions for older people. This is because
patients with longer life expectancy will have
a longer beneﬁt after treatment. Another
factor inﬂuencing life expectancy is gender,
that is, men have a lower life expectancy
compared with women. These differences can
be substantial. For example, in the European
Union, women live up to 11.7 years longer
than men.
5 Also, between socioeconomic
classes, differences in life expectancy exist.
People in the lower socioeconomic classes
have a lower life expectancy compared with
those in the higher socioeconomic classes.
6 In
the Netherlands, newborn boys in the lowest
socioeconomic class live on average 7.2 years
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ARTICLE SUMMARY
Article focus
- How do people value different attributes relative
to other attributes in the context of healthcare
resource allocation decisions?
- How does the validity of the besteworst scaling
method compare with the willingness pay
method?
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Open Access Protocolshorter compared with their counterparts in the highest
socioeconomic class.
7 Because of these differences in life
expectancy, similarly effective treatments can be less cost-
effective in populations with lower life expectancy. QALYs
also favour pre-intervention health states representing
high quality of life over health states representing lower
quality of life.
8 Harris described an example of such
a situation in which twin sisters get involved in a car
accident. Before the accident, one was living in perfect
health, while the other was not. After the accident,
a treatment could save their lives and recover both to their
pre-accident health state. In this case, the one who lived in
perfect health before the accident would gain more
QALYs and therefore would be prioritised for treatment.
This implies that in case of life-saving treatment, treated
morbidity is prioritised over treated co-morbidity.
Finally, the use of QALYs is criticised for the fact that
society has been involved in valuing health states but not
in other factors incorporated in QALY calculations like
the chance of treatment success, the number of people
in need of the intervention or life expectancy after
treatment.
9 10 If, as a result, resource allocation fails to
recognise societal preferences, there is a danger that an
increasing number of people are no longer willing to pay
for standard health insurance.
Consequently, empirical knowledge about factors
inﬂuencing societal preferences and the relative impor-
tance of these factors is necessary. Numerous studies have
been conducted to measure how society prioritises
healthcare resources. Most of these studies measured
preferences on one attribute at a time and, as such, their
relative importance is unknown.
11 Therefore, a study will
be conducted with the aim to measure the relative
importance society puts on different attributes when they
are presented simultaneously. Furthermore, previous
studies measured societal preferences in a variety of ways,
for example, by means of discrete choice experiments,
person trade-off, time trade-off or willingness to pay
(Unpublished data: I. van der Wulp et al.). A relatively
new method in studies on healthcare resource allocation
preferences is besteworst scaling. Besteworst scaling is an
extension of discrete choice experiments in that respon-
dents choose both the best and the worst option from
a choice set.
12 It is unknown whether the validity of this
method is better compared with the validity of other
methods. This is important in decisions on what prefer-
ence elicitation method to apply in a study. Previous
studies on the validity of preference elicitation methods
were often focused on one method at a time.
13 14 As
a result, comparing the validity of preference elicitation
methods is hampered as most studies also differ on several
other aspects. A secondary aim of this study therefore is to
compare the validity of the besteworst scaling method
with that of the willingness to pay method.
Study questions
How do people value different attributes relative to
other attributes in the context of healthcare resource
allocation decisions?
How does the validity of the best-worst scaling method
compare to the willingness pay method?
METHODS AND ANALYSIS
Study design
Societal preferences are studied in a cross-sectional
design.
Study setting and population
A sample of 2000 Dutch citizens over 18 years of age,
who are able to speak and read Dutch, are selected by
a market research agency. The market research agency
has a panel consisting of over 50000 people. From this
panel, a representative sample of respondents is
approached by email for participation in the study. This
sample will be representative for the Dutch population
on age, gender and education status. Respondents are
asked to complete a web-based questionnaire containing
treatment scenarios. The treatment scenarios present
different levels of attributes.
Selection of attributes
The selection of attributes in this study is primarily based
on two critics on the use of QALYs, implicit weightings
inherent in the QALY and a lack of societal involvement
in the valuation of attributes.
4 8e10 However, because
numerous attributes are associated with the components
of a QALY that cause implicit weightings, that is, life
expectancy and quality of life, a restriction in the selec-
tion of attributes is made. This is to prevent that the task
becomes too complex for respondents. The restriction
includes only those attributes that have been studied
previously because of implicit QALY weightings. As
a result, the following attributes related to implicit
weightings are selected: age, gender, socioeconomic
status, pre-intervention health state and treatment effect.
Chance of treatment success and number of people in
need of the intervention are selected for their current
lack of societal involvement.
Attribute levels
The selection of attribute levels depends, among other
things, on the shape of the expected effects, that is, if
linear effects are expected, two levels with a wide range
can be selected, while if non-linear effects are expected
more attribute levels are needed.
15
Furthermore, to limit the number of treatment
scenarios necessary for an efﬁcient design, it is recom-
mended to use as few attribute levels as possible and as
little variation in the number of attribute levels as
possible.
Age
In a previous study, Tsuchiya
16 reported that younger
respondents’ preferences concerning age were approxi-
mately linear, while those of older people were more
convex. A linear effect of the value of age in the present
study is therefore not to be expected and more than two
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selected ages representing different phases of the
human life span. The same approach is adopted for the
present study. The ages 5, 20, 35, 55 and 70 are selected
for the present study and derived from Tsuchiya et al.
17
Gender
Previous studies including gender as attribute focused
on men and women only.
18e24 Most studies have not
found preferences for one or the other and assume that
people prefer interventions for complaints occurring in
both sexes. To check this assumption, in the present
study, this attribute consists of three levels, interventions
for men, women or both sexes.
Socioeconomic status
Several studies have expressed only one of the three
aspects of socioeconomic status (income, job position or
education status) to their respondents.
18e20 22e26 They
have reported mixed results. Mooney et al
26 and
Schwappach
27 have expressed all three aspects of socio-
economic status. In the present study, socioeconomic
status represents income, job position and education
status and is expressed as ‘high’ or ‘low’ status.
Pre-intervention health state and treatment effect
In previous studies, pre-intervention health state has
been expressed in a variety of ways, for example, by
means of a mobility scale, EQ-5D health states or utili-
ties.
28 29 A combination of the latter two is used in the
present study by means of presenting utilities combined
with the corresponding EQ-5D health state descriptions.
Dolan
29 used utilities 20, 40, 60, 80 and 100. For the
present study, the utilities 20, 40 and 50 are used to
express pre-intervention health states. To determine the
treatment effect, the attribute post-intervention health
state is incorporated in the scenarios in the same way as
pre-intervention health state. Post-intervention health
states are expressed with utilities 60, 80 and 100. This is
to test whether respondents value equal gains equally or
whether large gains are valued higher than small gains.
In addition, respondents are asked to assume that
each post-intervention health state lasts for 1 year.
For the ease of interpretation, the utilities are expressed
on a Visual Analogue Scale derived from the EQ-5D
(table 1).
30
Chance of treatment success
In previous studies, this attribute was described as
prognosis, probability of gain, probability of 5-year
survival after treatment or the chance of treatment
success.
9 31e33 An advantage of the latter description is
that it ﬁts chronic as well as acute health states, that is,
treatment success does not implicate recovery. It is
therefore used in the present study. For the attribute
levels, it is considered important to incorporate a prob-
ability of 100% as this is a frequently observed outcome
in minor health problems and is qualitatively different
from the lower levels of success. To cover a full spectrum
of prognoses, the other two attribute levels are derived
from Ubel and Loewenstein,
34 35 that is, 10% and 50%.
Number of people in need of intervention
In previous studies, this attribute has either been
expressed as the number of deaths prevented due to the
intervention or the number of patients that could be
treated.
9 26 36e40 The ﬁrst description can be interpreted
as an effect of a preventive intervention, which is not the
purpose of this attribute in the present study. Therefore,
the second description is used. The prevalence of
diseases and complaints in the Netherlands was studied
to determine the attribute levels.
41 The following attri-
bute levels ranging from relatively rare to relatively
common are selected: 3000, 60000 and 240000 patients.
Data collection
The data are collected by means of a web-based survey.
This survey registers respondents’ age, gender, socio-
economic status, health state and whether respondents
have additional health insurance for treatments not
covered by the standard health insurance package, such
as dental care. Health state is measured by means of the
EQ-5D.
30 Societal preferences are measured by means of
treatment scenarios (table 2).
In the besteworst scaling task, respondents are
presented with ﬁve sets of four treatment scenarios. This
is to prevent respondents for dropping out of the study
because of the number of complex tasks that need to be
Table 1 Expression of health states
Health
state Example of Euroqol health state
0e20 Conﬁned to bed
Unable to wash or dress one selves
Unable to perform usual activities
Experiences no pain or discomfort
Is moderately anxious or depressed
21e40 Conﬁned to bed
Unable to wash or dress one selves
No problems with performing usual activities
Experiences no pain or discomfort
Is not anxious or depressed
41e60 No problems in walking about
No problems with self-care
No problems with performing usual activities
Experiences extreme pain or discomfort
Not anxious or depressed
61e80 No problems in walking about
No problems with self-care
No problems with performing usual activities
Experiences no pain or discomfort
Is moderately anxious or depressed
81e100 No problems in walking about
No problems with self-care
No problems with performing usual activities
Experiences no pain or discomfort
Not anxious or depressed
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scenarios the best and the worst scenario depending on
the framing of the questionnaire. This is known as case 3
or multi-attribute proﬁle besteworst scaling.
42
Two questionnaire versions are developed. Half of the
respondents are informed that within the standard
health insurance package, there is room for one addi-
tional intervention in each set of scenarios. Further-
more, they are informed that each treatment scenario is
as costly as another treatment scenario in the same set.
Respondents are subsequently asked to select from each
set one treatment which they prefer to be covered by the
standard health insurance package (best) and one
treatment they prefer not be covered (worst). The other
half of the respondents are informed that from each set
of scenarios, one treatment should be removed from the
standard health insurance package because of increasing
healthcare costs. They are asked to indicate in each set of
scenarios which treatment they prefer to be kept covered
by the standard health insurance package (best) and
which treatment they prefer to be removed from this
insurance package (worst). The ﬁrst besteworst task is
equal for all respondents. In this task, only the number
of people in need of the intervention differs between the
scenarios, while all other attributes are held constant.
This is to test whether respondents understand the task.
In a pilot test of the questionnaire, it appeared that 75%
of the respondents ﬁlled in the expected answer. After
each besteworst scaling task, respondents indicate the
difﬁculty of the decision-making task.
In the willingness to pay task, four separate scenarios
are presented to respondents. In these tasks, the same
types of framing are presented. Half of the respondents
are asked by means of an open-ended question how
much additional premium they are willing to pay
monthly for each of the individual treatments to be
covered by the standard health insurance package. The
other half are asked to indicate how much additional
premium they are willing to pay each month to prevent
that the treatment is removed from the standard health
insurance package. In both questionnaire versions, they
are also asked to indicate their certainty about the
amount they are willing to pay and to assume that their
monthly health insurance premium is V100 (the
approximate average premium for the compulsory
health insurance package in the Netherlands).
The presented scenarios in the willingness to pay task
correspond to one of the sets of the besteworst scaling
task. By means of computerised randomisation, respon-
dents receive either the besteworst scaling part or
the willingness to pay part of the questionnaire ﬁrst
(ﬁgure 1).
After completing both tasks, they are asked how
important (on a 0e10 scale) they consider the attributes
under study in the allocation of scarce healthcare
resources.
Overall, the questionnaire is framed in an ex ante
personally inclusive social perspective, that is, respon-
dents are asked to state their preferences as a member of
society while being uncertain about the extent they will
use healthcare resources in the future.
43
Selection of treatment scenarios
With the before-mentioned selection of attribute levels,
a full factorial design consists of 2430 treatment
scenarios (233
535). The full factorial design is created
with the AlgDesign package in R for Windows V.2.10.1
(appendix A).
44 The design was initially blocked by
means of a nested balanced incomplete block design in
122 blocks with each block consisting of 20 treatment
scenarios. Each block was subsequently blocked into ﬁve
blocks each consisting of four scenarios by means of
a balanced incomplete block design. However, in a pilot
test of the questionnaire, the resulting besteworst
scaling task appeared to be too difﬁcult for respondents
as too many attribute levels changed between the four
scenarios of each task. All blocks have the same struc-
ture, for example, in the ﬁrst half of the scenarios,
socioeconomic status is high, while being low in the
second half. Therefore, each of the 122 blocks is allo-
cated into ﬁve sets of four scenarios in the order in
Table 2 Example of treatment scenario
Treatment A
Age 35-year-olds
Gender Men
Socioeconomic status High
Number of people in need of intervention 60000
Pre-intervention health state 20 of 100
Post-intervention health state 80 of 100
Number of patients in which treatment is
successful
10 of 100
Figure 1 Flow diagram data
collection.
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scenarios in this way, less variation occurs between the
scenarios of a task.
In selecting a balanced incomplete block design, one
can set the number of repeated procedures. By
repeating the procedure, the AlgDesign package selects
n sets of blocked scenarios and compares this selection
with the previous selections. From these, the most efﬁ-
cient blocked design is selected.
45 By increasing the
number of repeated procedures, it is more likely that the
most efﬁcient combination of blocks is selected.
However, also the computational time increases
substantially. When selecting the most efﬁcient model
from all possible combinations of 2430 scenarios
R should repeat the selection procedure 1.96310
49
times (2430!/(20!(2430e20)!)). As this is too time
consuming, the repeated procedures command was set
to 50000. The resulting balanced incomplete block
design has substantial diagonality, 0.866, which indicates
a relatively small amount of confounding in the design.
Also a minimal loss of variance due to blocking is
observed (geometric mean of efﬁciencies: 0.998).
Data analyses
As respondents ﬁrst choose a scenario that they consider
as ‘best’ and subsequently choose a scenario that is
considered the ‘worst’ option from a choice set, these
data are analysed by means of a sequential conditional
logit model. In this analysis, the characteristics of
scenarios chosen by respondents as ‘best’ receive a value
of 1. The remaining three scenarios not chosen as ‘best’
are valued 0. The scenarios chosen as ‘worst’ receive
a value of 1 and the remaining two scenarios not
chosen either as ‘best’ or ‘worst’ are valued 0.
In conditional logit modelling, three types of
independent variables can be estimated.
46
First, generic alternative-speciﬁc variables, which are
the attributes that vary in the treatment scenarios. In the
present study, these variables are age, gender, socioeco-
nomic status, pre-intervention health state, treatment
effect, chance of treatment success and the number of
people in need of the intervention. Second, alternative-
speciﬁc variables that vary between the treatment
scenarios but have a different impact on the choice
alternative, that is, the framing type in the present study.
Finally, individual-speciﬁc variables which include
respondent characteristics, that is, age, gender, socio-
economic status, EQ-5D health state, type of insurance
and the degree of difﬁculty for choosing a ‘best’ and
‘worst’ treatment scenario. The resulting b coefﬁcients
from the analysis reﬂect the impact of a generic alter-
native-speciﬁc variable on the likelihood of choosing
another treatment scenario.
46 However, these coefﬁ-
cients cannot be used to calculate the relative impor-
tance of the attributes as they are biased by underlying
utility scale values of each attribute.
47 Therefore, the
relative importance of each attribute is determined by
means of the partial log-likelihood method, that is, by
omitting attributes one by one from the model and
calculating the overall log likelihood.
The willingness to pay data are analysed by means of
analysis of variance. In these analyses, the amount of
money people are willing to pay for an intervention is
the dependent variable. The independent variables are
the attributes, the respondents’ characteristics (age,
gender, socioeconomic status, EQ-5D health state and
type of insurance), the likelihood respondents actually
want to pay the chosen amount and the framing type of
the questionnaire. In the analyses, the independent
variables are tested univariately. Variables signiﬁcantly
(p<0.05) associated with either the besteworst scaling
outcome or willingness to pay are selected for multivar-
iate analysis. In multivariate analyses, the main
effects will be corrected for seven-way interactions as all
attributes are presented to respondents simultaneously.
To determine the validity of the besteworst scaling and
willingness to pay method, the resulting relative impor-
tance scores of the attributes from both analyses are
compared with the rating scores of attributes by means
of Pearson correlation coefﬁcients. All analyses are
performed in R for Windows V.2.10.1.
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